Sentences with phrase «late stage technology companies»

Not exact matches

In a recent fireside chat, Dennis Chookaszian, the long - time CEO of CNA Insurance and more recently a substantial angel and early - stage investor and advisor to numerous companies, departed from the usual plethora of pompous pieties that seem to pass for content at technology panel discussions of late.

Prior to Corixa, Mr. Christianson served for 12 years overseeing manufacturing and site operations at RIBI ImmunoChem Research, a biopharmaceutical company developing late - stage adjuvant technology.

Toronto, July 27, 2011 — Eight Ontario companies have received more than $ 6 million in seed and later stage financing from the Investment Accelerator Fund (IAF), a program that invests in eligible companies as they develop their technologies and bring their products or services to market.

We invest in early - stage venture projects with world - class technologies and entrepreneurs; later - stage companies with existing customers, strong sales and top tier management and co-investors.

OMERS Ventures invests in early to late stage companies in the Technology, Media, and Telecommunications sectors.

Eight Ontario companies have received more than $ 6 million in seed and later stage financing from the Investment Accelerator Fund (IAF), a program that invests in eligible companies as they develop their technologies and bring their products or services to market.

Drawing from decades of experience with cutting edge technologies, both as a founder and an operator, Beyda looks to invest in startups and later - stage companies solving real problems with cutting - edge technology.

EDMONTON, July 24, 2012 — Alberta Enterprise Corporation today announced that it has invested $ 6 million as a limited partner in Avrio Ventures II, an Alberta venture capital fund that invests in later - stage food and agricultural technology, including bio-products, nutraceutical ingredients and food technology companies.

May 18, 2010 — Alberta Enterprise, a fund of funds manager investing in knowledge - based industries, today announced a $ 14 Million investment in the latest fund from Yaletown Venture Partners, a venture capital (VC) firm focused on seed and early - stage companies in the Information Technology and Clean Technology sectors.

The Company invests in private equity, private debt, private real estate investments, early and late - stage technology investments, special situation investments, alternative asset funds managed by the Company and structured finance investments.»

Led by OrbiMed Advisors, an investment management firm focused on the healthcare sector, Caduceus Private Investment funds invest primarily in US mid and late stage private life science companies and medical technologies.

Adams Street's Direct Investment team makes $ 5 million to $ 20 million investments into late - stage and growth companies in the technology and healthcare spaces and has made over 240 investments since 1972.

Table 1: Selection, Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection, Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection, Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection, Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection, Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection, Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored Clinical Trials of T - Vec Table 8: Clinical Trials of ColoAd1 Table 9: Clinical Trials with JX - 594 Table 10: Clinical Trials with GL - ONC1 Table 11: Clinical Trials of CAVATAK (CVA21) Table 12: Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study Design of Oncolytic Viruses in Late Stage Development Based on Previous Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 18: Planned Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned Clinical Studies of Oncolytic Viruses in Combination with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions

«Nobody wishes they went public today or over the last week,» Max Wolff, the chief economist at Manhattan Venture Partners, an investment firm focusing on late - stage private technology companies, told Bloomberg.

Its name Kai meaning» Pioneer», the Mazda KAI CONCEPT compact hatchback sets the stage for the future of the Mazda brand, showcasing the company's breakthrough technologies and the latest evolution of its KODO design.

Traditionally, Apple has been content to stay a step behind the latest processor technology, and reap the power efficiency benefits, and that's just what we heard it would do again... but today, right now on stage, the Cupertino computer company unveiled a mobile chip with quad core graphics, not a quad - core CPU.

Technology companies that enter the E / N platform receive access to the full spectrum of corporate counsel: from dedicated, responsive early - stage focused attorneys to late - stage M&A partners who've managed high - stakes transactions as partners at the country's leading large firms.